Renin-angiotensin system inhibitor exerts prognostic effects in HFpEF patients with low baseline chloride level.

Shota Shirotani,Kentaro Jujo,Takuma Takada,Takuro Abe,Makoto Kishihara,Shonosuke Watanabe,Nana Endo, Hiroko Fujita,Satoshi Murasaki,Junichi Yamaguchi

International journal of cardiology（2023）

引用 1|浏览9

暂无评分

摘要

RASi administration was associated with an improved prognosis only in HFpEF patients with a low baseline serum chloride level. Clinicians should consider RASi administration if patients' serum chloride levels are low, to improve the long-term prognosis of HFpEF patients.

查看译文

关键词

Heart failure with preserved ejection fraction,Renin-angiotensin system,Serum chloride

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要